About This Comparison
Our Editorial Standards
This weight loss provider comparison is independently researched by our editorial team. We compare telehealth services based on publicly available information including pricing, available treatments, service areas, and verified customer reviews.
Not Medical Advice: This comparison is for informational purposes only. We are not healthcare providers. Always consult with a licensed physician before starting any treatment. Read our full medical disclaimer and editorial policy.
Best Tirzepatide Online (9 Compared)
Tirzepatide is a GLP-1 and GIP dual receptor agonist medication used for weight management. Available as brand medications Zepbound and Mounjaro, tirzepatide has shown higher average weight loss in clinical trials compared to semaglutide. Online telehealth platforms now offer both brand and compounded tirzepatide with prescriptions and home delivery.
What Is Tirzepatide and How Does It Work?
- Dual GIP and GLP-1 receptor agonist targeting two appetite pathways
- Weekly self-administered subcutaneous injection
- Available as Zepbound, Mounjaro, and compounded formulations
- First-in-class dual-action weight management medication
SURMOUNT Trial Results: What the Clinical Data Shows
- SURMOUNT-1: up to 20.9% average weight loss at highest dose
- 91% of patients on 15 mg lost at least 5% body weight
- 57% of patients on 15 mg lost at least 20% body weight
- 2,539 patients studied over 72 weeks
Tirzepatide vs Semaglutide: Which Produces Better Results?
- Tirzepatide produced nearly double the weight loss in real-world data
- No significant difference in serious gastrointestinal side effects
- SURPASS-2 showed tirzepatide superior for diabetes outcomes too
- Individual response and cost should guide the decision
Zepbound vs Mounjaro vs Compounded Tirzepatide
- Zepbound is FDA-approved specifically for weight management
- Mounjaro is approved for type 2 diabetes with significant weight loss
- Compounded tirzepatide offers the same ingredient at to monthly
- All three are available through telehealth platforms
Tirzepatide Dosing Schedule and What to Expect
- Starting dose of 2.5 mg weekly for 4 weeks
- Gradual increase to maintenance of 5, 10, or 15 mg
- 20-week dose escalation period
- Appetite reduction typically noticed within first 2 weeks
Managing Tirzepatide Side Effects
- Gastrointestinal effects are the most common but usually mild
- Nausea, diarrhea, and vomiting are typically transient
- Less than 5% discontinued due to side effects in SURMOUNT-2
- Eating smaller meals and staying hydrated helps significantly
Who Qualifies for Tirzepatide Treatment Online?
- BMI of 30 or higher qualifies for weight management
- BMI of 27 or higher with weight-related conditions may qualify
- Thyroid cancer history is a contraindication
- Online providers conduct full medical screening before prescribing
Real-World Results Outside Clinical Trials
- 81.8% achieved at least 5% weight loss in real-world practice
- 62.1% achieved at least 10% weight loss
- Results confirm clinical trial findings in routine settings
- Study included over 18,000 patients across US health systems
Long-Term Weight Management with Tirzepatide
- Weight management is a chronic condition requiring ongoing care
- Stopping treatment typically leads to partial weight regain
- Building sustainable habits during treatment supports lasting results
- Your provider may adjust your dose over time as needed
Choosing the Right Tirzepatide Provider
- Verify the provider uses licensed compounding pharmacies
- Ensure thorough medical evaluation before prescribing
- Look for ongoing medical supervision and regular check-ins
- Compare total costs including medication, consults, and shipping
Frequently Asked Questions
How much does tirzepatide cost through online telehealth in 2026?
Compounded tirzepatide costs between $199 and $500 per month through telehealth platforms. Brand Zepbound and Mounjaro cost $1000 to $1200 per month without insurance or savings programs. The significant cost difference makes compounded tirzepatide an accessible option for many patients seeking weight management treatment.
Is tirzepatide better than semaglutide for weight loss?
Clinical trials showed tirzepatide produced higher average weight loss than semaglutide - approximately 20 to 22 percent versus 15 to 17 percent of body weight. However, both medications are highly effective and individual results vary. Your provider can help determine which is better for your specific situation based on cost, availability, and your health profile.
How much weight can I expect to lose on tirzepatide?
Clinical trials showed average weight loss of approximately 20 to 22 percent of body weight at the 15 mg dose over 72 weeks. About 57 percent of patients lost 20 percent or more of their body weight. Individual results vary based on starting weight, dosing, adherence, diet, exercise, and other factors.
Do I need a prescription for tirzepatide?
Yes, tirzepatide requires a prescription from a licensed healthcare provider. Telehealth platforms connect you with licensed doctors or nurse practitioners who evaluate your eligibility based on BMI and medical history. Typical qualifying criteria include BMI of 30 or higher, or BMI of 27 or higher with weight-related health conditions.
What is the difference between Zepbound and Mounjaro?
Zepbound and Mounjaro both contain tirzepatide. Zepbound is indicated specifically for weight management while Mounjaro is indicated for type 2 diabetes. The dosing schedules are similar but not identical. Insurance coverage differs - Mounjaro may be covered for diabetes but not weight loss, while Zepbound coverage depends on your specific plan.
How long does it take to see results with tirzepatide?
Most people notice reduced appetite within one to two weeks of starting tirzepatide. Visible weight loss typically becomes apparent after two to three months at therapeutic doses. Maximum results are usually achieved at 12 to 18 months. The dose escalation schedule takes several months to reach higher therapeutic doses.
What are common side effects of tirzepatide?
Common side effects include nausea, diarrhea, constipation, decreased appetite, and vomiting. These are usually most noticeable when starting or increasing doses and typically improve within a few weeks. Serious side effects are rare but can include pancreatitis and gallbladder problems.
Can I use tirzepatide if I have diabetes?
Yes, tirzepatide can be used by people with type 2 diabetes. Mounjaro is specifically indicated for diabetes treatment. The medication helps with both weight loss and blood sugar control. If you have diabetes, your provider may need to adjust other diabetes medications to avoid low blood sugar during tirzepatide treatment.
Is compounded tirzepatide as effective as Zepbound or Mounjaro?
Compounded tirzepatide contains the same active ingredient as Zepbound and Mounjaro. While compounded medications are not approved in the same way as brand names, they use the same active pharmaceutical ingredient. Effectiveness depends on proper dosing and adherence. Many patients report similar results with compounded versions at significantly lower cost.
Which telehealth platform is best for tirzepatide?
The best platform depends on your priorities. Hims, Hers, and Ro offer affordable compounded tirzepatide starting around $199 to $350 per month. Henry Meds focuses specifically on affordable GLP-1 access. Eden and Strut also offer tirzepatide programs. Compare pricing, program features, provider support, and customer reviews when choosing.
Sources & References
Our comparisons are informed by official sources and regulatory guidelines. We encourage readers to verify information with authoritative sources.
- Tirzepatide is a first-in-class medication that works as a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptor agonist
- The SURMOUNT-1 trial enrolled 2,539 adults with obesity over 72 weeks and tested three tirzepatide doses against placebo
- The SURMOUNT-2 trial in 938 adults with obesity and type 2 diabetes showed 12.8% weight loss at 10 mg and 14.7% at 15 mg over 72 weeks, with 79 to 83% achieving at least 5% loss
- The SURPASS-2 trial directly compared tirzepatide to semaglutide 1 mg in type 2 diabetes and found tirzepatide produced greater A1C reductions and 1.9 to 5.5 kg more weight loss across doses
Editorial Note: Researched and edited by our editorial team. AI tools assist with initial research and drafting; all content is fact-checked and edited by humans before publication. Learn more about our editorial standards